116 related articles for article (PubMed ID: 32546699)
1. ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy.
Guberina M; Sak A; Pöttgen C; Tinhofer-Keilholz I; Budach V; Balermpas P; Von der Grün J; Rödel CM; Gkika E; Grosu AL; Abdollahi A; Debus J; Belka C; Pigorsch S; Combs SE; Mönnich D; Zips D; De-Colle C; Welz S; Linge A; Lohaus F; Baretton G; Gauler T; Baumann M; Krause M; Schuler M; Bankfalvi A; Höing B; Lang S; Stuschke M
Pharmacogenomics J; 2021 Feb; 21(1):37-46. PubMed ID: 32546699
[TBL] [Abstract][Full Text] [Related]
2. Biomarker signatures for primary radiochemotherapy of locally advanced HNSCC - Hypothesis generation on a multicentre cohort of the DKTK-ROG.
Löck S; Linge A; Lohaus F; Ebert N; Gudziol V; Nowak A; Tinhofer I; Kalinauskaite G; Guberina M; Stuschke M; Balermpas P; von der Grün J; Grosu AL; Debus J; Ganswindt U; Belka C; Peeken JC; Combs SE; De-Colle C; Zips D; Baretton GB; Krause M; Baumann M;
Radiother Oncol; 2022 Apr; 169():8-14. PubMed ID: 35182686
[TBL] [Abstract][Full Text] [Related]
3. Association of DNA repair gene variants with colorectal cancer: risk, toxicity, and survival.
Salimzadeh H; Lindskog EB; Gustavsson B; Wettergren Y; Ljungman D
BMC Cancer; 2020 May; 20(1):409. PubMed ID: 32397974
[TBL] [Abstract][Full Text] [Related]
4. Effects of ERCC2 Lys751Gln (A35931C) and CCND1 (G870A) polymorphism on outcome of advanced-stage squamous cell carcinoma of the head and neck are treatment dependent.
Zhong S; Nukui T; Buch S; Diergaarde B; Weissfeld LA; Grandis J; Romkes M; Weissfeld JL
Cancer Epidemiol Biomarkers Prev; 2011 Nov; 20(11):2429-37. PubMed ID: 21890746
[TBL] [Abstract][Full Text] [Related]
5. Variants in nucleotide excision repair core genes and susceptibility to recurrence of squamous cell carcinoma of the oropharynx.
Song X; Sturgis EM; Jin L; Wang Z; Wei Q; Li G
Int J Cancer; 2013 Aug; 133(3):695-704. PubMed ID: 23335232
[TBL] [Abstract][Full Text] [Related]
6. ERCC1 and ERCC2 variants predict survival in gastric cancer patients.
Li Y; Liu Z; Liu H; Wang LE; Tan D; Ajani JA; Wei QY
PLoS One; 2013; 8(9):e71994. PubMed ID: 24023723
[TBL] [Abstract][Full Text] [Related]
7. Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study.
Hardi H; Melki R; Boughaleb Z; El Harroudi T; Aissaoui S; Boukhatem N
BMC Cancer; 2018 Mar; 18(1):292. PubMed ID: 29544444
[TBL] [Abstract][Full Text] [Related]
8.
Costa EFD; Lima TRP; Lopes-Aguiar L; Nogueira GAS; Visacri MB; Quintanilha JCF; Pincinato EC; Calonga L; Mariano FV; Altemani AMAM; Altemani JMC; Moriel P; Chone CT; Ramos CD; Lima CSP
Tumour Biol; 2020 Jul; 42(7):1010428320938494. PubMed ID: 32628088
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between ERCC2 single nucleotide polymorphisms and male idiopathic infertility in Ningxia].
Liu CL; Jiao HY; Ma Q; Wu X; Jia ST; Jing WH; Yang QH
Zhonghua Nan Ke Xue; 2014 May; 20(5):419-22. PubMed ID: 24908732
[TBL] [Abstract][Full Text] [Related]
10. Debio 1143 and high-dose cisplatin chemoradiotherapy in high-risk locoregionally advanced squamous cell carcinoma of the head and neck: a double-blind, multicentre, randomised, phase 2 study.
Sun XS; Tao Y; Le Tourneau C; Pointreau Y; Sire C; Kaminsky MC; Coutte A; Alfonsi M; Boisselier P; Martin L; Miroir J; Ramee JF; Delord JP; Clatot F; Rolland F; Villa J; Magne N; Elicin O; Gherga E; Nguyen F; Lafond C; Bera G; Calugaru V; Geoffrois L; Chauffert B; Zubel A; Zanna C; Brienza S; Crompton P; Rouits E; Gollmer K; Szyldergemajn S; Bourhis J
Lancet Oncol; 2020 Sep; 21(9):1173-1187. PubMed ID: 32758455
[TBL] [Abstract][Full Text] [Related]
11. Genetic variability of genes in NER pathway influences the treatment outcome of gastric cancer.
Xue MH; Li GY; Wu XJ; Zhang CX; Zhang CF; Zhu KX
Int J Clin Exp Pathol; 2015; 8(5):5563-9. PubMed ID: 26191265
[TBL] [Abstract][Full Text] [Related]
12. Effect of
Zhang H; Li Y; Guo S; Wang Y; Wang H; Lu D; Wang J; Jin L; Jiang G; Wu J; Han Y; Li J
Am J Transl Res; 2020; 12(10):6941-6953. PubMed ID: 33194084
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of ERCC2, ABCC2 and MMP2 of response and long-term survival in locally advanced head and neck cancer patients treated with chemoradiotherapy.
Duran G; Cruz R; Aguín S; Barros F; Giráldez JM; Bernárdez B; Zarra I; López-López R; Carracedo Á; Lamas MJ
Cancer Chemother Pharmacol; 2021 Nov; 88(5):813-823. PubMed ID: 34309735
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of ERCC1 and ERCC2 gene polymorphisms in patients with gastric cancer receiving platinum-based chemotherapy.
Mo J; Luo M; Cui J; Zhou S
Int J Clin Exp Pathol; 2015; 8(11):15065-71. PubMed ID: 26823845
[TBL] [Abstract][Full Text] [Related]
15. Genetic variability of ERCC1 and ERCC2 influences treatment outcomes in gastric cancer.
Yu WH; Wang YX; Guo JQ; Wang YL; Zheng JS; Zhu KX
Genet Mol Res; 2015 Dec; 14(4):17529-35. PubMed ID: 26782397
[TBL] [Abstract][Full Text] [Related]
16. Influence of ERCC2 gene polymorphisms on the treatment outcome of osteosarcoma.
Liu ZF; Asila AL; Aikenmu K; Zhao J; Meng QC; Fang R
Genet Mol Res; 2015 Oct; 14(4):12967-72. PubMed ID: 26505449
[TBL] [Abstract][Full Text] [Related]
17. Genetic variability of genes involved in DNA repair influence treatment outcome in osteosarcoma.
Wang MJ; Zhu Y; Guo XJ; Tian ZZ
Genet Mol Res; 2015 Sep; 14(3):11652-7. PubMed ID: 26436406
[TBL] [Abstract][Full Text] [Related]
18. HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
Lohaus F; Linge A; Tinhofer I; Budach V; Gkika E; Stuschke M; Balermpas P; Rödel C; Avlar M; Grosu AL; Abdollahi A; Debus J; Bayer C; Belka C; Pigorsch S; Combs SE; Mönnich D; Zips D; von Neubeck C; Baretton GB; Löck S; Thames HD; Krause M; Baumann M;
Radiother Oncol; 2014 Dec; 113(3):317-23. PubMed ID: 25480095
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of ERCC2 haplotype-tagging single nucleotide polymorphisms in patients with unresectable non-small cell lung cancer treated with first-line platinum-based chemotherapy.
Kim SH; Lee GW; Lee MJ; Cho YJ; Jeong YY; Kim HC; Lee JD; Hwang YS; Kim IS; Lee S; Oh SY
Lung Cancer; 2012 Sep; 77(3):578-84. PubMed ID: 22608006
[TBL] [Abstract][Full Text] [Related]
20. DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy.
Quintela-Fandino M; Hitt R; Medina PP; Gamarra S; Manso L; Cortes-Funes H; Sanchez-Cespedes M
J Clin Oncol; 2006 Sep; 24(26):4333-9. PubMed ID: 16896002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
